# ERBA Diagnostics, Inc.

ERBA Diagnostics, Inc. is a company headquartered in Miami, FL, United States.

## Company overview

- **Legal name:** ERBA Diagnostics, Inc.
- **Former names in filing history:** IVAX DIAGNOSTICS INC (2001-05-14 to 2012-06-15); B2BSTORES COM INC (1999-10-06 to 2001-03-14)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Miami, FL, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001095858

## About

ERBA Diagnostics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001095858, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2015-05-15, it reported annual revenue of USD 26,391,600; net income of USD 449,605; total assets of USD 26,195,785 for the fiscal period ended 2014-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $26.4M (USD 26,391,600)
- **Net income:** $449,605 (USD 449,605)
- **Total assets:** $26.2M (USD 26,195,785)
- **Cash and equivalents:** $2.5M (USD 2,548,295)
- **Operating cash flow:** -$537,788 (USD -537,788)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $5.1M (USD 5,138,000)
- **Net income:** $675,828 (USD 675,828)
- **Total assets:** $25.9M (USD 25,874,466)
- **Cash and equivalents:** $4.0M (USD 4,031,071)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $5.0M (USD 5,032,000)
- **Net income:** -$1.6M (USD -1,553,356)
- **Total assets:** $24.6M (USD 24,553,768)
- **Cash and equivalents:** $4.1M (USD 4,125,818)
- **Operating cash flow:** $201,706 (USD 201,706)
- **Later filings:** Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

### FY2011 (period ended 2011-12-31)

- **Revenue:** $16.8M (USD 16,759,773)
- **Net income:** -$3.3M (USD -3,297,343)
- **Total assets:** $17.2M (USD 17,206,884)
- **Cash and equivalents:** $3.7M (USD 3,653,244)
- **Operating cash flow:** -$2.8M (USD -2,849,595)

## Recent SEC filings

- Form 8-K — filed 2020-07-08 — period 2020-07-02 — FORM 8-K
- Form 8-K — filed 2020-07-06 — period 2020-06-23 — FORM 8-K
- Form 8-K — filed 2020-06-17 — period 2020-06-17 — FORM 8-K
- Form 8-K — filed 2020-05-11 — period 2020-05-08 — FORM 8-K
- Form 8-K — filed 2020-04-16 — period 2020-04-13 — FORM 8-K
- Form 8-K — filed 2020-03-23 — period 2020-03-20 — FORM 8-K
- Form 8-K — filed 2020-01-06 — period 2020-01-03 — FORM 8-K
- Form 8-K — filed 2019-11-22 — period 2019-11-07 — FORM 8-K
- Form 8-K — filed 2019-11-13 — period 2019-11-06 — FORM 8-K
- Form 8-K — filed 2019-09-20 — period 2019-09-18 — FORM 8-K
- Form 8-K — filed 2019-07-02 — period 2019-07-01 — FORM 8-K
- Form 8-K — filed 2019-06-18 — period 2019-06-17 — FORM 8-K

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/erba-diagnostics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology